Concept of Viral Inhibitors via NTCP
Identification of sodium taurocholate cotransporting polypeptide (NTCP) as an entry receptor for hepatitis B and D viruses (HBV and HDV) has not only promoted our understanding of the mechanism underlying the viral entry process, but also provided cell culture models supporting viral infection. Thes...
Saved in:
| Published in | Seminars in liver disease Vol. 39; no. 1; p. 78 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
01.02.2019
|
| Online Access | Get more information |
Cover
Loading…
| Abstract | Identification of sodium taurocholate cotransporting polypeptide (NTCP) as an entry receptor for hepatitis B and D viruses (HBV and HDV) has not only promoted our understanding of the mechanism underlying the viral entry process, but also provided cell culture models supporting viral infection. These models have greatly facilitated cell-based chemical screening for the discovery of entry inhibitors, and mode of action studies using such inhibitors have shown the advantages of NTCP as a drug target. Furthermore, in vitro chemical screening by application of high-throughput affinity-based technologies that target NTCP has identified a variety of unique small molecules that interfere with viral entry. This review summarizes this hot topic in the development of HBV/HDV entry inhibitors, with special focus on the use of NTCP as a drug target. |
|---|---|
| AbstractList | Identification of sodium taurocholate cotransporting polypeptide (NTCP) as an entry receptor for hepatitis B and D viruses (HBV and HDV) has not only promoted our understanding of the mechanism underlying the viral entry process, but also provided cell culture models supporting viral infection. These models have greatly facilitated cell-based chemical screening for the discovery of entry inhibitors, and mode of action studies using such inhibitors have shown the advantages of NTCP as a drug target. Furthermore, in vitro chemical screening by application of high-throughput affinity-based technologies that target NTCP has identified a variety of unique small molecules that interfere with viral entry. This review summarizes this hot topic in the development of HBV/HDV entry inhibitors, with special focus on the use of NTCP as a drug target. |
| Author | Watashi, Koichi Wakita, Takaji Tsukuda, Senko Fukano, Kento |
| Author_xml | – sequence: 1 givenname: Kento surname: Fukano fullname: Fukano, Kento organization: Department of Analytical Biochemistry, Meiji Pharmaceutical University, Kiyose, Japan – sequence: 2 givenname: Senko surname: Tsukuda fullname: Tsukuda, Senko organization: Liver Cancer Prevention Research Unit, RIKEN Center for Integrative Medical Sciences (IMS), Wako, Japan – sequence: 3 givenname: Koichi surname: Watashi fullname: Watashi, Koichi organization: JST CREST, Saitama, Japan – sequence: 4 givenname: Takaji surname: Wakita fullname: Wakita, Takaji organization: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30809790$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1zjtLBDEUQOEgivvQ1lJS2EZvksnjljL4WFjUYrVdkniDkd2ZYTIK_nsFtTrdx1mww67viLEzCZcSjLmqAkB7Ia2zHpoDNpeAXnh0csYWtb4DgMIGjtlMgwd0CHN20fZdomHifeYvZQw7vureSixTP1b-WQJ_2LRPJ-woh12l078u2fPtzaa9F-vHu1V7vRZJI07CJG20Chpl-uG9aiBZCsaRk8mgktInRYmMtTKTJ4xJIcWYEX2GxoJasvNfd_iIe3rdDmPZh_Fr-7-rvgEStT75 |
| CitedBy_id | crossref_primary_10_1002_med_21664 crossref_primary_10_1177_24725552211017500 crossref_primary_10_1016_j_fct_2024_114665 crossref_primary_10_3390_ph14050417 crossref_primary_10_3748_wjg_v27_i24_3530 crossref_primary_10_3390_v13040666 crossref_primary_10_1152_ajpgi_00263_2020 crossref_primary_10_1038_s41598_020_78618_2 crossref_primary_10_3390_v14040764 crossref_primary_10_1080_14728222_2021_1915990 crossref_primary_10_1128_JVI_00938_21 crossref_primary_10_3390_livers1040019 crossref_primary_10_3390_biomedicines10010196 crossref_primary_10_3389_fmolb_2021_689757 crossref_primary_10_1007_s00204_022_03396_x crossref_primary_10_1016_j_bbrc_2023_07_014 crossref_primary_10_1097_COH_0000000000000623 crossref_primary_10_3389_fmolb_2022_879817 crossref_primary_10_1016_j_jpha_2024_100979 crossref_primary_10_3390_v12060648 crossref_primary_10_1021_acs_bioconjchem_3c00464 crossref_primary_10_1016_j_gene_2022_147068 |
| ContentType | Journal Article |
| Copyright | Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA. |
| Copyright_xml | – notice: Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA. |
| DBID | NPM |
| DOI | 10.1055/s-0038-1676804 |
| DatabaseName | PubMed |
| DatabaseTitle | PubMed |
| DatabaseTitleList | PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1098-8971 |
| ExternalDocumentID | 30809790 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: JP18fk0310114j0002, JP18fk0310101j1002, JP18fk0310103j0202, JP18fm0208019j0002, JP18fk0210036j0001, 18fm0208019h0202 grantid: Japan Agency for Medical Research and Development, AMED – fundername: JP17H04085, JP66KT0111, JP16K19145 grantid: Japan Society for the Promotion of Science KAKENHI |
| GroupedDBID | --- .GJ 0R~ 123 1UC 34G 39C 3O- 4.4 53G 5RE 5~~ AAIWL AAKAS AAQQT ABJNI ABOCM ABZLV ACGFO ACGFS ACNUY ADZCM AENEX AEVEF AFFNX AGCGI AHRAW AHRSK AIVKU AJGCD AKJTW ALMA_UNASSIGNED_HOLDINGS BPGNG C45 CAG COF CS3 DU5 EBS EJD EXEOM F5P H13 IY8 L7B N9A NPM O9- OVD P2P Q3R QTC RIG ROL RTC TEORI ZGI ZXP |
| ID | FETCH-LOGICAL-c399t-5c3532a391c8098240c6ea57e71c592118c2ece5661fe8e9bc29ebbf998f04602 |
| IngestDate | Mon Jul 21 05:45:41 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c399t-5c3532a391c8098240c6ea57e71c592118c2ece5661fe8e9bc29ebbf998f04602 |
| PMID | 30809790 |
| ParticipantIDs | pubmed_primary_30809790 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-02-01 |
| PublicationDateYYYYMMDD | 2019-02-01 |
| PublicationDate_xml | – month: 02 year: 2019 text: 2019-02-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Seminars in liver disease |
| PublicationTitleAlternate | Semin Liver Dis |
| PublicationYear | 2019 |
| SSID | ssj0002940 |
| Score | 2.384151 |
| SecondaryResourceType | review_article |
| Snippet | Identification of sodium taurocholate cotransporting polypeptide (NTCP) as an entry receptor for hepatitis B and D viruses (HBV and HDV) has not only promoted... |
| SourceID | pubmed |
| SourceType | Index Database |
| StartPage | 78 |
| Title | Concept of Viral Inhibitors via NTCP |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30809790 |
| Volume | 39 |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwELVYJMQFse8oB24o0Cx24yOqqBASFRJluVW2MxYh0FY05cDXM7aTtpRFwCWK7CSy85zJG9szj5DDGDRLOaU-02gC4zpQn4OSvtRBJEWMFlHY3RYtdn4TX9zT-7EYp40uKeSxevsyruQ_qGIZ4mqiZP-A7OihWIDniC8eEWE8_grjhos5NITvNnuxWTMeMplZAZ3XTBy12o2rSfZ5bTKJoCdrJjmezIaM6fWZ5jAXVovbxOsUvZFbPxjmw9TSzGvo5qPyO1EYLSZ7fS9TD9m4Is8cLW2LXDxmk3MLJpxptE8DnD006UYT7lRSKoPpsg99GBjO-jkxnk9GuUZN_oqBb1Yh_YChg-MUhycQ6j9biCLkr7zu9EN_rp1Kkl1VzZJZdBeM_qmZtCl_yCGPa1W-TkpPPjZkkSxUN095FpZhtJfJUukaeKcO5xUyA91VsnBZbn5YI4cl3F5PexZubwy3h3B7Bu51ctM8azfO_VLkwlfIDQufqohGoYh4oLAVCRIsxUDQOtQDRTm654kKQQGy7kBDAlyqkIOUGt1kbRa1ww0y1-11YYt4UNMsSkXCWBrFyDQlUykoTqXQFL_CaJtsuv51-i6TSafq-c63NbtkcTww9si8xk8H9pGHFfLAvuV3ahwueg |
| linkProvider | National Library of Medicine |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Concept+of+Viral+Inhibitors+via+NTCP&rft.jtitle=Seminars+in+liver+disease&rft.au=Fukano%2C+Kento&rft.au=Tsukuda%2C+Senko&rft.au=Watashi%2C+Koichi&rft.au=Wakita%2C+Takaji&rft.date=2019-02-01&rft.eissn=1098-8971&rft.volume=39&rft.issue=1&rft.spage=78&rft_id=info:doi/10.1055%2Fs-0038-1676804&rft_id=info%3Apmid%2F30809790&rft_id=info%3Apmid%2F30809790&rft.externalDocID=30809790 |